Parvovirus B19 infection in a human immunodeficiency virus-infected patient with anemia

Journal of the Formosan Medical Association

Volumn 99, Issue 2, 2000, Pages 162-165

  Lau, Sheung Mei ^a,b   Yu, Wen Liang ^a   Chow, Kuan Chih ^a   Wang, Jen Hsien ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anemia; Human immunodeficiency virus; Parvovirus B19; Zidovudine

Indexed keywords

LAMIVUDINE; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTE CONCENTRATE; ERYTHROPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADULT; ANEMIA; ANTI-HIV AGENTS; ERYTHEMA INFECTIOSUM; HIV INFECTIONS; HUMANS; MALE; ZIDOVUDINE;

EID: 0034112369     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brown KE, Young NS, Lin JM: Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994;16:1-31.
2. Chernak E, Dubin G, Henry D, et al: Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:170-3.
3. Anderson LJ, Torok TJ: Human parvovirus B19. N Engl J Med 1989;321:536-8.
4. Erdman DD, Usher MJ, Tsou C, et al: Human parvovirus B19 specific IgG. IgA and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991;35:110-5.
5. Durigon EL, Erdman DD, Gary GW, et al: Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 1993;44:155-65.
6. Sullivan PS, Hanson DL, Chu SY, et al: Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;1:301-8.
7. Richman DD, Fishl MA, Grieco MH, et al: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blinded, placebo controlled trial. N Engl J Med 1987;317:192-7.
8. Chiu CF, Chow KC, Lin FM, et al: Expression of DNA topisomerase IIα and multidrug resistance p-glycoprotein in acute leukemia. Chung Hua I Hsueh Tan Chih (Taipei) 1997;60:184-90.
9. Sun T, Li CY, Yarn LT. Histochemistry. In: Sun T, Li CY, Lam LT, eds. Atlas of Cytochemistry and Immunocytochemistry of Hematologic Neoplasms. Chicago: American Society Clinical Pathologists Press, 1985:90-133.
10. Gyllensten K, Sonnerborg A, Jorup-Ronstrom C, et al: Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 1994;22:356-8.
11. Groopman JE: Management of hematologic complications of human immunodeficiency virus infection. Rev Infect Dis 1990;12:931-7.
12. Camacho J, Poveda F, Zamorano AF, et al: Serum erythropoietin levels in patients with advanced human immunodeficiency virus infection. Br J Haematol 1992; 82:608-14.
13. Horsburgh VR: Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991:324;1332-8.
14. Keisu M, Wiholm BE, Palmblad J: Trimethoprimsulphamethoxazole-associated blood dyscrasias. Ten years' experiences of the Swedish spontaneous reporting system. J Intern Med 1990:228;353-60.
15. Faulds D, Heel RC: Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficiency in cytomegalovirus infection. Drugs 1990:39; 597-638.
16. van Elsacker-Niele AMW, Kroon FP, van der Ende ME, et al: Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23:1255-60.
17. Hsieh SM, Hung CC, Chen MY, et al: Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection. J Microbiol Immunol Infect 1998;31:233-9.
18. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor of B19 parvovirus. Science 1993; 262:114-7.
19. Lui W, Ittmann M, Liu J, et al: Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry. Hum Pathol 1997; 28:760-6.
20. Frickhofen N, Abkowitz JL, Safford M, et al: Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-33.
21. Clewley JP: Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989;27: 2647-51.
22. Abkowitz JL, Brown KE, Wood RW, et al. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997;176:269-73.
23. Ellaurie M, Burns ER, Rubinstein A. Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol 1990;12:499.
24. Young NS: Parvovirus infection and its treatment. Clin Exp Immunol 1996;104(suppl 1):26-30.
25. Mylonakis E, Dickinson BP, Mileno MD, et al: Persistent parvovirus B19 related anemia of seven years' duration in an HIV-intected patient: complete remission associated with high active antiretroviral therapy. Am J Hematol 1999; 60:164-6.
26. Volberding PA, Lagakos SW, Koch MA, et al: Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 1990;322:941-9.